BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Leucine-rich glioma inactivated 1 (LGI1)

January 22, 2015 8:00 AM UTC

In vitro and mouse studies suggest 4-phenylbutyrate or its analogs could help treat autosomal dominant lateral temporal lobe epilepsy (ADLTE), which is caused by LGI1 mutations with unknown functions....